Gene · 92140
Papers2,305
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,305
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metadherin orchestrates PKA and PKM2 to activate β-catenin signaling in podocytes during proteinuric chronic kidney disease. | Transl Res | 2024 | 37995969 | PubTator, text mining | PubMed |
| Dual role of CASP8AP2/FLASH in regulating epithelial-to-mesenchymal transition plasticity (EMP). | Transl Oncol | 2024 | 37984255 | PubTator, text mining | PubMed |
| MTDH enhances radiosensitivity of head and neck squamous cell carcinoma by promoting ferroptosis based on a prognostic signature. | J Radiat Res | 2024 | 37981296 | PubTator, text mining | PubMed |
| Linc00239 Promotes Colorectal Cancer Development via MicroRNA-182-5p/Metadherin Axis. | Biochem Genet | 2024 | 37695492 | PubTator, text mining | PubMed |
| Gigantol protects retinal pigment epithelial cells against high glucose-induced apoptosis, oxidative stress and inflammation by inhibiting MTDH-mediated NF-kB signaling pathway. | Immunopharmacol Immunotoxicol | 2024 | 37681978 | PubTator, text mining | PubMed |
| Autophagy-related lncRNAs in tumor progression and drug resistance: A double-edged sword. | Genes Dis | 2024 | 37588204 | PubTator, text mining | PubMed |
| Exploring binding modes of the selected inhibitors to SND1 by all-atom molecular dynamics simulations. | J Biomol Struct Dyn | 2024 | 37345536 | PubTator, text mining | PubMed |
| Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment. | Front Chem | 2023 | 38264122 | PubTator, text mining | PubMed |
| Unraveling the Epigenetic Tapestry: Decoding the Impact of Epigenetic Modifications in Hidradenitis Suppurativa Pathogenesis. | Genes (Basel) | 2023 | 38254928 | PubTator, text mining | PubMed |
| LncRNAs in non-small cell lung cancer: novel diagnostic and prognostic biomarkers. | Front Mol Biosci | 2023 | 38152110 | PubTator, text mining | PubMed |
| Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma-A Narrative Review. | Pharmaceutics | 2023 | 38140058 | PubTator, text mining | PubMed |
| Hippo pathway in intestinal diseases: focusing on ferroptosis. | Front Cell Dev Biol | 2023 | 38130953 | PubTator, text mining | PubMed |
| Expression of Tumor Suppressor FHIT Is Regulated by the LINC00173-SNAIL Axis in Human Lung Adenocarcinoma. | Int J Mol Sci | 2023 | 38069335 | PubTator, text mining | PubMed |
| [Research Progress of LncRNA SNHGs in Regulating the Biological Behavior of Non-small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2023 | 38061887 | PubTator, text mining | PubMed |
| Risk model-guided identification of MTDH expression as a marker for ferroptosis induction therapy in head and neck squamous cell carcinoma. | Am J Cancer Res | 2023 | 38058815 | PubTator, text mining | PubMed |
| An anoikis-related lncRNA signature is a useful tool for predicting the prognosis of patients with lung adenocarcinoma. | Heliyon | 2023 | 38053861 | PubTator, text mining | PubMed |
| Identification and validation of disulfidptosis-related gene signatures and their subtype in diabetic nephropathy. | Front Genet | 2023 | 38028597 | PubTator, text mining | PubMed |
| Advances in the relationship between ferroptosis and epithelial-mesenchymal transition in cancer. | Front Oncol | 2023 | 38023171 | PubTator, text mining | PubMed |
| Unraveling the Janus-Faced Role of Autophagy in Hepatocellular Carcinoma: Implications for Therapeutic Interventions. | Int J Mol Sci | 2023 | 38003445 | PubTator, text mining | PubMed |
| SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer. | Nat Commun | 2023 | 37973913 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92140/papers?page=7